10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A longitudinal observational retrospective study on risk factors and predictive model of PICC associated thrombosis in cancer patients

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To analyze the incidence of PICC associated venous thrombosis. To predict the risk factors of thrombosis. To validate the best predictive model in predicting PICC associated thrombosis. Consecutive oncology cases in 341 who initially naive intended to be inserted central catheter for chemotherapy, were recruited to our dedicated intravenous lab. All patients used the same gauge catheter, Primary endpoint was thrombosis formation, the secondary endpoint was infusion termination without thrombosis. Two patients were excluded. 339 patients were divided into thrombosis group in 59 (17.4%) and non-thrombosis Group in 280 (82.6%), retrospectively. Tumor, Sex, Age, Weight, Height, BMI, BSA, PS, WBC, BPC, PT, D-dimer, APTT, FIB, Smoking history, Location, Catheter length, Ratio and Number as independent variables were analyzed by Fisher’s scoring, then Logistic risk regression, ROC analysis and nomogram was introduced. Total incidence was 17.4%. Venous mural thrombosis in 2 (3.4%), “fibrin sleeves” in 55 (93.2%), mixed thrombus in 2 (3.4%), symptomatic thrombosis in 2 (3.4%), asymptomatic thrombosis in 57 (96.6%), respectively. Height (χ² = 4.48, P = 0.03), D-dimer (χ² = 37.81, P < 0.001), Location (χ² = 7.56, P = 0.006), Number (χ² = 43.64, P < 0.001), Ratio (χ² = 4.38, P = 0.04), and PS (χ² = 58.78, P < 0.001), were statistical differences between the two groups analyzed by Fisher’s scoring. Logistic risk regression revealed that Height (β = −0.05, HR = 0.95, 95%CI: 0.911–0.997, P = 0.038), PS (β = 1.07, HR = 2.91, 95% CI: 1.98–4.27, P < 0.001), D-dimer (β0.11, HR = 1.12, 95% CI: 1.045–1.200, P < 0.001), Number (β = 0.87, HR = 2.38, 95% CI: 1.619–3.512, P < 0.001) was independently associated with PICC associated thrombosis. The best prediction model, D-dimer + Number as a novel co-variable was validated in diagnosing PICC associated thrombosis before PICC. Our research revealed that variables PS, Number, D-dimer and Height were risk factors for PICC associated thrombosis, which were slightly associated with PICC related thrombosis, in which, PS was the relatively strongest independent risk factor of PICC related thrombosis.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.

          Long-term central venous catheters (CVCs) have considerably improved the management of cancer patients because they facilitate chemotherapy, transfusions, parenteral nutrition, and blood sampling. However, the use of long-term CVCs, especially for chemotherapy, has been associated with the occurrence of upper-limb deep venous thrombosis (UL-DVT). The incidence of clinically overt UL-DVT related to CVCs has been reported to vary between 0.3% and 28.3%. The incidence of CVC-related UL-DVT screened by venography reportedly varies between 27% and 66%. The incidence of clinically overt pulmonary embolism (PE) in patients with CVC-related UL-DVT ranges from 15% to 25%, but an autopsy-proven PE rate of up to 50% has been reported. Vessel injury caused by the procedure of CVC insertion, venous stasis caused by the indwelling CVC, and cancer-related hypercoagulability are the main pathogenetic factors for CVC-related venous thromboembolism (VTE). Several studies have assessed the benefit of the prophylaxis of UL-DVT after CVC insertion in cancer patients. According to the results of these studies, prophylaxis with low molecular weight heparin or a low fixed dose of warfarin has been recently proposed. However, the limitations of the experimental design of the prophylactic studies do not allow definitive recommendations. The recommended therapy for UL-DVT associated with CVC is based on anticoagulant therapy with or without catheter removal. This review focuses on the epidemiology, pathogenesis, diagnosis, prevention, and treatment of VTE in cancer patients with long-term CVC.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence.

            The widespread use of peripherally inserted central catheters (PICCs) has transformed the care of medical and surgical patients. Whereas intravenous antibiotics, parenteral nutrition, and administration of chemotherapy once necessitated prolonged hospitalization, PICCs have eliminated the need for such practice. However, PICCs may not be as innocuous as once thought; a growing body of evidence suggests that these devices also have important risks. This review discusses the origin of PICCs and highlights reasons behind their rapid adoption in medical practice. We evaluate the evidence behind 2 important PICC-related complications--venous thrombosis and bloodstream infections--and describe how initial studies may have led to a false sense of security with respect to these outcomes. In this context, we introduce a conceptual model to understand the risk of PICC-related complications and guide the use of these devices. Through this model, we outline recommendations that clinicians may use to prevent PICC-related adverse events. We conclude by highlighting important knowledge gaps and identifying avenues for future research in this area.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Risk of symptomatic DVT associated with peripherally inserted central catheters.

              Previous studies undertaken to identify risk factors for peripherally inserted central catheter (PICC)-associated DVT have yielded conflicting results. PICC insertion teams and other health-care providers need to understand the risk factors so that they can develop methods to prevent DVT.
                Bookmark

                Author and article information

                Contributors
                1360016771@qq.com
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                22 June 2020
                22 June 2020
                2020
                : 10
                : 10090
                Affiliations
                [1 ]ISNI 0000 0001 0706 7839, GRID grid.506261.6, Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, , Chinese Academy of Medical Sciences and Peking Union Medical College, ; ShenZhen, 518116 China
                [2 ]ISNI 0000 0001 0706 7839, GRID grid.506261.6, Administrative Department of Nurse, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, , Chinese Academy of Medical Sciences and Peking Union Medical College, ; ShenZhen, 518116 China
                [3 ]ISNI 0000 0001 0706 7839, GRID grid.506261.6, Department of Ultrasound, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, , Chinese Academy of Medical Sciences and Peking Union Medical College, ; ShenZhen, 518116 China
                [4 ]Department of Ultrasound, The third people’s Hospital of ChangZhou, JiangSu Province, 213001 China
                [5 ]ISNI 0000 0001 0706 7839, GRID grid.506261.6, Department of Intravenous lab, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, , Chinese Academy of Medical Sciences and Peking Union Medical College, ; ShenZhen, 518116 China
                Article
                67038
                10.1038/s41598-020-67038-x
                7308336
                32572092
                a70aa6c2-6357-47b4-8d3a-680068b56da3
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 25 November 2019
                : 2 June 2020
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                cancer imaging,risk factors
                Uncategorized
                cancer imaging, risk factors

                Comments

                Comment on this article